🇺🇸 FDA
Pipeline program

IMMUNE RESET TO ALLOW ACCESS TO HLA-COMPATIBLE KIDNEY TRANSPLANTATION IN HYPERIMMUNIZED PATIENTS

HIPER-RESET

Phase 2 other active

Quick answer

IMMUNE RESET TO ALLOW ACCESS TO HLA-COMPATIBLE KIDNEY TRANSPLANTATION IN HYPERIMMUNIZED PATIENTS for chronic kidney disease, Hypersensitized patients is a Phase 2 program (other) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
chronic kidney disease, Hypersensitized patients
Phase
Phase 2
Modality
other
Status
active

Clinical trials